Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Yale Cancer Biology Institute, Yale University, West Haven, CT, USA.
Nature. 2021 Dec;600(7887):148-152. doi: 10.1038/s41586-021-04141-7. Epub 2021 Nov 24.
The proto-oncogene ALK encodes anaplastic lymphoma kinase, a receptor tyrosine kinase that is expressed primarily in the developing nervous system. After development, ALK activity is associated with learning and memory and controls energy expenditure, and inhibition of ALK can prevent diet-induced obesity. Aberrant ALK signalling causes numerous cancers. In particular, full-length ALK is an important driver in paediatric neuroblastoma, in which it is either mutated or activated by ligand. Here we report crystal structures of the extracellular glycine-rich domain (GRD) of ALK, which regulates receptor activity by binding to activating peptides. Fusing the ALK GRD to its ligand enabled us to capture a dimeric receptor complex that reveals how ALK responds to its regulatory ligands. We show that repetitive glycines in the GRD form rigid helices that separate the major ligand-binding site from a distal polyglycine extension loop (PXL) that mediates ALK dimerization. The PXL of one receptor acts as a sensor for the complex by interacting with a ligand-bound second receptor. ALK activation can be abolished through PXL mutation or with PXL-targeting antibodies. Together, these results explain how ALK uses its atypical architecture for its regulation, and suggest new therapeutic opportunities for ALK-expressing cancers such as paediatric neuroblastoma.
原癌基因 ALK 编码间变性淋巴瘤激酶,这是一种受体酪氨酸激酶,主要在发育中的神经系统中表达。在发育后,ALK 的活性与学习和记忆有关,并控制能量消耗,抑制 ALK 可以预防饮食诱导的肥胖。异常的 ALK 信号会导致多种癌症。特别是全长 ALK 是小儿神经母细胞瘤的重要驱动因素,它在神经母细胞瘤中要么发生突变,要么被配体激活。在这里,我们报告了 ALK 的细胞外甘氨酸丰富结构域 (GRD) 的晶体结构,该结构域通过与激活肽结合来调节受体活性。将 ALK 的 GRD 与配体融合,使我们能够捕获二聚体受体复合物,揭示了 ALK 如何对其调节配体作出反应。我们表明,GRD 中的重复甘氨酸形成刚性螺旋,将主要的配体结合位点与介导 ALK 二聚化的远端多甘氨酸延伸环 (PXL) 分开。一个受体的 PXL 通过与配体结合的第二个受体相互作用,充当复合物的传感器。通过 PXL 突变或 PXL 靶向抗体可以消除 ALK 的激活。这些结果共同解释了 ALK 如何利用其非典型结构进行调节,并为表达 ALK 的癌症(如小儿神经母细胞瘤)提供了新的治疗机会。